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Cystic fibrosis transmembrane conductance regulator gene (CFTR) shows a complex mechanism of tissue-specific and temporal
regulation. CFTR mRNA detection and measurement are extremely difficult because of the low to very low levels of its endogenous
expression. In this paper, we describe four different non-PCR methods optimized to analyze CFTR transcripts in epithelial cell lines, primary
cell lines and native tissues that express significant amounts of CFTR transcript.
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1. Introduction cases represent only a small percentage of the transcriptThe expression of the CFTR gene is tightly regulated
both temporally and spatially. CFTR mRNA is known to be
more abundant in the airway epithelium during the second
trimester of human development than after birth. This
change in abundance might reflect additional or different
roles for CFTR in the developing airway epithelium. Mul-
tiple start sites and alternative exon usage have also been
described for the CFTR transcript. These modifications of
the CFTR transcript could result in alterations in the protein,
which could be functionally important. However, so far, no
clear functional role has been elucidated for the products of
any of these different alternative CFTR transcripts. Even
though the analysis of CFTR transcripts is crucial for a
better understanding of the function and role of CFTR, these
have proven extremely difficult to study because of the low
to very low level of endogenous expression. This is partic-
ularly relevant for the alternative transcripts that in most1569-1993/$ - see front matter D 2004 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2004.05.005
Abbreviations: CFTR, cystic fibrosis transmembrane conductance
regulator; RACE, rapid amplification of cDNA ends; EtBr, ethidium
bromide; RB, running buffer; RT, reverse transcriptase; RNA-ISH, RNA in
situ hybridization.
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methods are largely used to study CFTR transcripts [1,2].
In this paper, we describe three different non-PCR methods
optimized to detect and measure CFTR transcripts in epi-
thelial cells that express significant amounts of CFTR
transcript, as well as primary cell lines and native tissues.
Although Northern blotting using total RNA is extremely
difficult in native tissues and primary cell lines, due to very
low levels of endogenous expression, we report a method
that allows the detection of endogenous CFTR mRNA in
epithelial cells that express CFTR in significant amounts,
the colonic cell lines HT-29 [5] and Caco-2 [3] as well as the
respiratory Calu-3 cells [4], a line derived from the submu-
cosal gland and can also be used with polyA+ RNA from
primary tissues or to analyze the expression of CFTR in
heterologous systems expressing high levels of CFTR such
as CHO or BHK stably expressing CFTR. The variant of
this technique that we described was successfully used to
study the surface expression of the CFTR mutant, F508del
[6]. The second method is an RNA in situ hybridization
optimized for detection of CFTR mRNA in vivo [7]. We
address a number of critical factors such as tissue fixation,
sectioning, type and labeling choice of probe, probe pene-
tration of tissue, background blocking, hybridization, and
method of signal detection that combine to determine theed by Elsevier B.V. All rights reserved.
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scribed is a rapid amplification of cDNA ends (RACE). This
method was used successfully to identify alternative 5V
exons of the ovine CFTR gene [8]. All protocols discussed
here are described in detail at the European Working Group
on CFTR Expression website [9].1 More details are available on request from the author A. Trezise:
ann.trezise@uq.edu.au.2. Methods
2.1. Northern blotting
After RNA extraction, RNA concentration is determined
by measurement of absorbance at 260 nm. To be able to
compare, the same amount of total RNA must be loaded in
each lane. To each RNA sample (about 20 Ag resuspended
in a maximum of 4.5 Al), add formamide, formaldehyde and
5 Running Buffer (RB) (40 mM MOPS, 10 mM sodium
acetate, 1 mM EDTA pH 7.0) to the final concentrations of
50% (v/v), 2.3 M and 1 , respectively. Denature the
samples for 15 min at 65 jC, immediately cool on ice and
add the loading buffer (50% (v/v) glycerol, 1 mM EDTA,
0.04% (w/v) bromophenol blue and 0.04% (w/v) xylene
cyanol blue) to a final volume of 22 Al. Load an appropriate
molecular weight standard (e.g., RNA ladder 1.24–9.5 kb)
and the RNA samples on a 1% or 2% (w/v) agarose gel
prepared in 1RB and formaldehyde 2.3 M. Run electro-
phoresis either at 100 V for 2–3 h or overnight (16–18 h) at
50 V in 1RB. After electrophoresis, cut off the lane
corresponding to the RNA ladder, stain it with ethidium
bromide (EtBr) 0.5 Ag/ml for 15 min, remove the excess of
EtBr in two distilled water washes (5 min each) and
photograph under UV. Rinse the gel two to three times with
distilled water for 5 min to remove the excess of formalde-
hyde and soak it into 20 SSC (3 M NaCl and 0.3 M
sodium citrate pH 7.0) for 30 min to neutralize it. Set the
blot to transfer overnight using 20 SSC as described
elsewhere [10]. To speed up and increase efficiency of
transfer, change the wet paper towels for a new set of dry
ones at least once during the transfer. After transfer, wash
the nitrocellulose/nylon filter twice rapidly with 2 SSC,
air dry it at room temperature and incubate it for 2 h at 80
jC. Pre-hybridize filters carrying RNA samples in hybrid-
ization buffer for at least 4 h at 42 jC. During this time, 200
ng of the EcoRI CFTR cDNA fragment corresponding to the
region 2226–3714 are radioactivity labeled according to the
manufacturer’s instructions using the Multiprime DNA
Labeling System (Amersham). The non-incorporated
nucleotides are removed by gel filtration using Sephadex
G-50 microcolumn (Boehringer Mannheim), according to
the manufacturer’s instructions. The labeled probe can be
stored at  20 jC at this step. Denature the probe by boiling
it for 3–5 min and add it to the minimum possible volume
of hybridization solution (5 SSC, 0.02% (w/v) Ficoll,
0.02% (w/v) PVP, 0.02% (w/v) BSA, 0.1% (w/v) SDS,
50% (v/v) formamide and 0.5 mg/ml sonicated salmonsperm DNA) needed to cover entirely the whole surface
of the filter. Hybridize overnight at 42 jC. Wash the filter
twice for 15 min at room temperature with wash solution I
(2 SSC, 0.1% (w/v) SDS) and once for 15 min at 50 jC
with wash solution II (0.1 SSC, 0.1% (w/v) SDS). Scan
the filter surface with Geiger counter and if necessary wash
once more for 15 min with wash solution II at 50 jC. Air
dry filter, expose it to Biomax film with intensifying screens
for 48 h at  70 jC or to phosphorimager. For re-probing,
wash filter for 2 h at 80 jC with wash solution II and
proceed directly to the pre-hybridization step.
Other CFTR cDNA fragments are commonly used as
probe. Primer sets needed to prepare CFTR cDNA fragment
to be used as a probe and a fragment of the mouse house
keeping gene h-actin (used as a loading control) by RT-PCR
are listed in Table 1.
2.2. RNA in situ hybridization1
The sensitivity of the procedure is determined by how
thoroughly tissue is fixed since the fixation step halts the
process of RNA degradation and to preserve the cellular and
tissue architecture during sectioning (for additional fixation
notes, see Ref. [11]). Post-fixation of tissue after sectioning
does not preserve the RNA sufficiently well to allow
detection of CFTR mRNA.
Fixative (Fix) A is 0.1 M NaOH, 40 g/l paraformaldehyde
and 13.6 g/l sodium acetate. Heat and stir to dissolve, do not
exceed 65 jC. Cool to 4 jC. Adjust the pH to 6.5 with
glacial acetic acid. Fix B is 0.1 M NaOH, 40 g/l parafor-
maldehyde and 0.05 M sodium tetraborate. Heat and stir to
dissolve, do not exceed 65 jC. Cool to 4 jC. Adjust the pH
to 9.5 with HCl. For tissue storage and post-fixation, make a
10% (w/v) sucrose Fix B. If ice crystal damage is still a
problem, the percentage sucrose can be increased anything
up to 30% (w/v). The correct preparation of microscope
slides (including coating with 3-aminopropyltriethoxysilane
is crucial for success [11]. Collect the required tissues into
Fix B with 10% sucrose and keep tissue at 4 jC for at least
48 h before sectioning. Tissue can be kept in this way for
many months. If perfusion fixation is not possible, then
collect tissue directly into Fix B + 10% (w/v) sucrose as
soon as possible after surgical removal. Place on a gently
rocking platform for 24 h at 4 jC. Keep the tissue samples
as small as possible to aid with fixative penetration.
Remove tissue from Fix B, rinse twice in 0.9% saline and
blot dry with filter paper. Using a disposable plastic mold,
embed tissue in O.C.T. embedding medium (Tissue Tek)
and freeze in liquid nitrogen. Store cut sections and remain-
ing frozen blocks at  80 jC in an airtight container. Before
use, place slides under vacuum at room temperature over-
night to dry sections onto slides or incubate the slides at 55
jC for 4 h.
Table 1
Sequences, location and GenBank accession number of oligonucleotides used to prepare cDNA probe specific to the human CFTR, human actin g or mouse
actin h gene by RT-PCR (h—human, m—mouse)
Primer sequence Orientation Gene and Location GenBank accession
number
5VACTGGAGCAGGCAAGACTTCA sense hCFTR, 1510–1530 NM_000492
5VCAGTGTGATTCCACCTTCTC antisense hCFTR, 1757–1775 NM_000492
5VAAGAACGTGCTTGTGGAAGAC sense hgActin, 2402–2422 M19283
5VGGTTACGGCAGCACTTTTATT antisense hgActin 2832–2812 M19283
5VTGTGATGGTGGGAATGGGTCA sense mhActin, 206–227 NM_007393
5VTTTGATGTCACGCACGATTTCC antisense mhActin, 698–719 NM_007393
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template for the probe synthesis reaction is a linear plasmid.
Add 10 Al 5 Transcription Buffer (200 mM Tris, pH 8.0,
40 mM MgCl2, 10 mM spermidine, 250 mM NaCl), 1 Al 10
mM ATP, 1 Al 10 mM CTP, 1 Al 10 mM GTP, 1 Al 750 mM
DTT, 1 Al RNase inhibitor (RNasin), 12.5 Al 35S-UTP
(Amersham, 10 mCi/ml, > 1000 Ci/mmol), 18 Al sterile
water, 1 Al DNA template (1 Ag), 1 Al T3 or T7 RNA
polymerase. Incubate at 37 jC for 3–4 h. Add 1 Al RNase
free DNase (RQ1 DNase, Promega) and incubate a further
10 min. Add 1 Al 0.5 M EDTA and 50 Al SET +DTT (1%
sodium dodecyl sulfate (SDS) in 10 mM Tris, pH 7.5, 1 mM
EDTA, 10 mM DTT) and vortex briefly. Prepare RNase Free
spin columns as described in Ref. [5] and apply probe, spin,
wash and collect eluate into a fresh tube. Count incorpo-
ration of label which should be about 90–100% incorpora-
tion with a final concentration of 1–3 106 cpm/Al in the
probe eluate from the column. Labeled probes should be
stored at  70 jC and used a soon as possible after labeling.
To pre-hybridize the slide-mounted frozen sections use
de-ionized, distilled water to make up wash solutions and
stock reagents at room temperature. Pre-heat the solution A
(25 ml of 1 M Tris–HCl (pH8.0), 250 Al of 10 mg/ml
proteinase K (Boehringer), 25 ml 0.5 M EDTA (pH 8.0) in
200 ml of distilled water) to 37 jC. Add slides and place
container in 37 jCwater bath for 2–20min. The exact timing
of the incubation will depend on the tissue being examined
and the abundance of the mRNA of interest [11]. Rinse in
0.2% glycine to stop the Proteinase K digestion. Post-fix in
Fix A for 5 min. Rinse in 0.1 M triethanolamine (TEA), pH
8.0, for 2 or 3 min. Acetylate for 10 min at room temperature
(625 Al of acetic anhydride (99% minimum purity) in 250 ml
0.1 M TEA pH8.0) to block positive charges on tissue
induced by proteinase K digestion. Rinse briefly and gently
in 2 SSC. Dehydrate quickly in ascending concentrations
(50–100%) of ethanol. Drain slides (5 min) and dry with
desiccant under vacuum at room temperature for at least 1
h until hybridization (can be left overnight).
The hybridization mix A consists of 25 ml freshly
deionised formamide (Fluka), 5 g dextran sulfate (Pharma-
cia), 3 ml 5 M NaCl, 1 ml 50Denhardt’s solution (1 g of
Ficoll (Sigma), 1 g of polyvinylpyrrolidone (Gibco) and 1 g
of Bovine Serum Albumin (BSA) Fraction V (Sigma) in 100
ml of sterile water), 0.5 ml 1 M Tris, pH 8.0 and sterilewater up to 40 ml final volume. Vortex thoroughly and heat
at 50–60 jC to dissolve dextran sulphate. Dilute your probe
in this solution before incubating with the tissue section. For
10 ml final volume of hybridization solution mix 500
Al tRNA (Sigma) 10 mg/ml in distilled water (kept frozen),
100 Al 1 M DTT (kept frozen)  Al of probe to obtain a
final probe concentration of 5 106 to 2 107 cpm/ml and
sterile water to bring the volume to 2 ml. Add 8 ml of
hybridization mix A and vortex thoroughly. The probe mix
can be stored at  70 jC. The hybridization solution stored
at  70 jC should be heated for 10 min at 65 jC for
denaturation and centrifuged before use. Once diluted
probes are stable at  70 jC for 2 weeks. Apply hybrid-
ization solution to cover slip: use about 80 Al for a 50 22
mm cover glass, proportionally less for smaller ones, then
place inverted slide carrying tissue section onto coverslip,
and place upright. Seal edges of cover glass with a line of
liquid D.P.X. mountant (BDH). Incubate overnight at 50 jC
on a slide warming tray in a fume hood.
For the post-hybridization RNase treatment and washes
use a rocking or rotating table for gentle agitation. Allow
slides to cool gradually to room temperature (30 min). Peel
off DPX. Place slide in slide rack immersed in 4 SSC.
Soak off cover slips in 4 SSC rinse (with gentle agitation
for20 min.). Lift slides out of rack, and let the cover glass
slide off. Place slides in another slide rack immersed in
4 SSC (RNase Staining Rack) and rinse twice in 4 SSC.
Pre-heat RNase solution (500 Al of 10 mg/ml RNase A
(Boehringer) (stored at  20 jC), 25 ml of 5 M NaCl, 2.5 ml
of 1 M Tris (pH 8.0), 500 Al of 0.5 M EDTA (pH 8.0) and
221.5 ml of distilled water) to 37 jC. Add slides and place
container in a 37 jC water bath for 30 min. RNase digestion
removes most of the non-specifically bound probe. Rinse
and wash at progressively increasing stringency of SSC
(starting from 2 up to 0.1 ) with 1 mM dithiothreitol
(DTT) added to all solutions by gently lifting slides in and
out of each solution five times and placing them on rocking
platform for 5 min for each wash at room temperature. For
the last wash preheat the washing solution (0.1 SSC) to 60
jC and place the slides in the 60 jC water bath for 30 min.
Briefly rinse the slides at room temperature in 0.1 SSC
with DTT to cool slides and dehydrate quickly in ethanol
with salt and DTT (add 1 ml 20 SSC and 250 Al 1 M DTT
per 250 ml) as before. Drain well (5 min.) and vacuum dry at
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stream of air for 60 min or in oven at 50 jC for 60 min. Slides
are now stable, and can be stored at room temperature.
Slides can be exposed to X-ray film and tissue sections
will produce a contact print image on the X-ray film with
the signal intensity proportional to the amount of bound
probe and therefore underlying gene expression. Relative
levels of mRNA expression can be obtained by densitomet-
ric analysis of contact sheet images [12].
Slides are then dipped in X-ray emulsion to be able to
detect a signal. Either Kodak Nuclear Tracking (NTB-2)
liquid emulsion or Ilford K5 liquid emulsion is used.
Dipping and developing is done in the darkroom with a
red safelight (Kodak Safelight Filter #2 with a 15-W bulb).
NTB-2/K5 is diluted with an equal volume of water plus a
couple of drops of glycerol, before dipping. Pre-warm an
appropriate amount of water/glycerol to 42 jC then add an
equal volume of NTB-2 and place at 42 jC to melt. Mix
thoroughly then pour into a Dip Miser Cup (Electron
Microscopy Sciences, USA, Cat #70510) and place back
at 42 jC. Hand dip each slide individually for approximate-
ly 4 s to achieve thin coverage of emulsion and then air dry
vertically for approximately 1 h. Place slides in slide boxes
and wrap the boxes in four layers of aluminium foil. Put the
slides at 4 jC to expose for the appropriate amount of time,
2 weeks in most cases. Kodak D19 developer is used to
develop in situ slides. When developing in situ slides, dilute
the amount of D19 stock needed 1:1 with water. Make sure
the temperature of the developer is 20F 2 jC. Develop
slides in Diluted Kodak D19 developer for precisely 4 min.
Rinse in 0.2% acetic acid to stop development and fix in
Kodak non-hardening fixer for 5 min. Rinse slides in
running tap water for at least 20 min before counter-
staining. After the emulsion has been developed, tissue
can be counter-stained with the stain of choice. (More
details are available at the Online Virtual Repository [11]).
2.3. Rapid amplification of cDNA ends (RACE)
This technique may be carried out efficiently with the
5VRACE kit from Roche (catalogue number: 1 734 792).
The synthesis of the first cDNA strand is performed
using 4 Al of 5AMV synthesis buffer (250 mM Tris–
HCl, 40 mM MgCl2, 150 mM KCl, 5 mM dithiotreitol, pH
8.5) mix with 2 Al of dNTP 10 mM (mixture of dATP, dTTP,
dGTP, dCTP 10 mM each), 1 Al of specific primer 12.5 AM,
a total of 0.2–2 Ag of RNA and 1 Al (20 U) of AMV reverse
transcriptase in a final volume of 20 Al. Incubate the
reaction at 55 jC for 1 h and then at 65 jC for 10 min.
After briefly spinning down, the reaction the cDNA is
purified using the High Pure PCR Product Purification Kit
(Roche) as per the manufacturer’s instructions. The polyA
tailing reaction of cDNA is performed as follows. Mix 19
Al of purified cDNA with 2.5 Al of 10 reaction buffer
(100 mM Tris–HCl, 15 mM MgCl2, 500 mM KCl, pH8.3)
and 2.5 Al of 2 mM dATP. Incubate for 3 min at 94 jC. Chillthe reaction on ice, briefly spin down the mixture and add 1
Al (10 U) of terminal transferase. Mix and incubate at 37 jC
for 20 min. To heat inactivate the enzyme, incubate at 70 jC
for 10 min. Briefly spin down the reaction and place the
tube on ice. The dA-tailed cDNA is then amplified in 50
Al total volume using 5 Al of dA-tailed cDNA, 1 Al of oligo
dT-anchor primer 37.5 AM (5V GACCACGCGTATC-
GATGTCGACTTTTTTTTTTTT TTTV 3VV=A, C or G),
1 Al of specific primer 12.5 AM, 1 Al dNTP 10 mM, 0.5 Al of
Taq DNA Polymerase and 5 Al of 10 reaction buffer. The
PCR conditions, 1 2 min at 94 jC followed by 10 15 s
at 94 jC, 30 s at the specific primer annealing temperature,
40 s at 72 jC and 25 15 s at 94 jC, 30 s at the specific
primer annealing temperature, 40 s at 72 jC plus a cycle
elongation of 20 s for each cycle and 1 7 min at 72 jC,
will depend on the specific primers used. A second round,
nested PCR, is sometimes necessary using 1 Al of the first
round PCR reaction and the same PCR condition. The least
robust part of this technique is the T-tailing reaction as
terminal transferase is a very unstable enzyme.Acknowledgements
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